Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protons | 2 | 2022 | 54 | 0.910 |
Why?
|
| Bone Substitutes | 1 | 2022 | 10 | 0.790 |
Why?
|
| Proton Therapy | 1 | 2022 | 29 | 0.770 |
Why?
|
| Breast Implants | 1 | 2021 | 6 | 0.740 |
Why?
|
| Iodine Radioisotopes | 2 | 2008 | 36 | 0.570 |
Why?
|
| Calibration | 2 | 2022 | 28 | 0.380 |
Why?
|
| Phantoms, Imaging | 2 | 2022 | 101 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2022 | 477 | 0.350 |
Why?
|
| Software | 2 | 2009 | 125 | 0.340 |
Why?
|
| Radiation Protection | 2 | 2008 | 18 | 0.320 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2009 | 2 | 0.310 |
Why?
|
| Radiation Monitoring | 1 | 2008 | 8 | 0.310 |
Why?
|
| Enzymes | 1 | 2009 | 23 | 0.300 |
Why?
|
| Nuclear Medicine | 1 | 2008 | 11 | 0.300 |
Why?
|
| Biological Assay | 1 | 2008 | 35 | 0.300 |
Why?
|
| Models, Chemical | 1 | 2009 | 90 | 0.300 |
Why?
|
| Occupational Exposure | 1 | 2008 | 28 | 0.300 |
Why?
|
| Health Personnel | 1 | 2008 | 95 | 0.280 |
Why?
|
| Renal Dialysis | 1 | 2006 | 52 | 0.260 |
Why?
|
| Algorithms | 2 | 2009 | 433 | 0.260 |
Why?
|
| Thyroid Neoplasms | 1 | 2006 | 39 | 0.250 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 69 | 0.250 |
Why?
|
| Models, Biological | 2 | 2006 | 465 | 0.230 |
Why?
|
| Butylated Hydroxyanisole | 1 | 2022 | 2 | 0.200 |
Why?
|
| Silicones | 1 | 2021 | 8 | 0.190 |
Why?
|
| Water | 1 | 2022 | 135 | 0.180 |
Why?
|
| Humans | 7 | 2022 | 28121 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2004 | 825 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 17 | 0.080 |
Why?
|
| Threshold Limit Values | 1 | 2008 | 2 | 0.080 |
Why?
|
| Body Burden | 1 | 2008 | 3 | 0.080 |
Why?
|
| Catalysis | 1 | 2009 | 133 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2009 | 230 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 242 | 0.070 |
Why?
|
| Thyroid Gland | 1 | 2006 | 32 | 0.070 |
Why?
|
| Radiotherapy Dosage | 1 | 2006 | 104 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2006 | 76 | 0.060 |
Why?
|
| Hyperalgesia | 1 | 2004 | 16 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2004 | 18 | 0.060 |
Why?
|
| Nociceptors | 1 | 2004 | 42 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2004 | 36 | 0.060 |
Why?
|
| Myelography | 1 | 2003 | 8 | 0.050 |
Why?
|
| Spinal Stenosis | 1 | 2003 | 15 | 0.050 |
Why?
|
| Spinal Cord Compression | 1 | 2003 | 25 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2003 | 58 | 0.050 |
Why?
|
| Thallium | 1 | 2002 | 2 | 0.050 |
Why?
|
| Whole-Body Counting | 1 | 2002 | 3 | 0.050 |
Why?
|
| Iridium Radioisotopes | 1 | 2002 | 3 | 0.050 |
Why?
|
| United States | 1 | 2008 | 2149 | 0.050 |
Why?
|
| Abdomen | 1 | 2002 | 42 | 0.050 |
Why?
|
| Cervical Vertebrae | 1 | 2003 | 119 | 0.050 |
Why?
|
| Endometrial Neoplasms | 1 | 2002 | 189 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 297 | 0.040 |
Why?
|
| Prephenate Dehydratase | 1 | 1999 | 1 | 0.040 |
Why?
|
| Fumarate Hydratase | 1 | 1999 | 4 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 521 | 0.020 |
Why?
|
| Pulmonary Edema | 2 | 1967 | 9 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 2021 | 0.020 |
Why?
|
| Middle Aged | 3 | 2004 | 7164 | 0.020 |
Why?
|
| Venoms | 1 | 1967 | 2 | 0.020 |
Why?
|
| Pulmonary Alveoli | 2 | 1967 | 33 | 0.020 |
Why?
|
| Lung | 2 | 1967 | 375 | 0.020 |
Why?
|
| Cytoplasm | 2 | 1966 | 57 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1967 | 31 | 0.020 |
Why?
|
| Adolescent | 2 | 2004 | 3123 | 0.020 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 1966 | 2 | 0.020 |
Why?
|
| Paresis | 1 | 2004 | 5 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 78 | 0.010 |
Why?
|
| Medical Audit | 1 | 2004 | 15 | 0.010 |
Why?
|
| Aged | 2 | 2004 | 5416 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 372 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 43 | 0.010 |
Why?
|
| Female | 3 | 2004 | 15156 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2002 | 18 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2002 | 56 | 0.010 |
Why?
|
| Intestinal Obstruction | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2004 | 886 | 0.010 |
Why?
|
| Adult | 2 | 2004 | 7757 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2002 | 51 | 0.010 |
Why?
|
| Myocardium | 1 | 2002 | 192 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 1249 | 0.010 |
Why?
|
| Male | 3 | 2004 | 13487 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 1999 | 31 | 0.010 |
Why?
|
| Microscopy, Electron | 3 | 1967 | 94 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1999 | 151 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1999 | 134 | 0.010 |
Why?
|
| Child | 1 | 2004 | 2242 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 545 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 2557 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 773 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1966 | 74 | 0.000 |
Why?
|
| In Vitro Techniques | 2 | 1966 | 242 | 0.000 |
Why?
|
| Snakes | 1 | 1967 | 8 | 0.000 |
Why?
|
| Alkaloids | 1 | 1967 | 16 | 0.000 |
Why?
|
| Rats | 2 | 1967 | 1564 | 0.000 |
Why?
|
| Animals | 4 | 1967 | 10399 | 0.000 |
Why?
|
| Surface-Active Agents | 1 | 1966 | 44 | 0.000 |
Why?
|
| Phospholipids | 1 | 1966 | 76 | 0.000 |
Why?
|
| Hypoxia | 1 | 1966 | 89 | 0.000 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1967 | 3 | 0.000 |
Why?
|
| Pulmonary Atelectasis | 1 | 1967 | 5 | 0.000 |
Why?
|
| Pulmonary Fibrosis | 1 | 1967 | 15 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1967 | 60 | 0.000 |
Why?
|